Tim Somervaille
Haematologist and Senior Group Leader at CRUK Manchester Institute studying the transcriptional drivers of acute myeloid leukaemia.
Overview
Tim Somervaille is a Senior Group Leader at the Cancer Research UK Manchester Institute, where his Leukaemia Biology laboratory investigates transcription factors and epigenetic regulators that sustain acute myeloid leukaemia. He is also a consultant haematologist at The Christie NHS Foundation Trust. His group has identified FOXC1 derepression as a recurrent feature in AML and explored EP300/CBP bromodomain inhibition as a therapeutic strategy.
Pages like this
not linked directly; found by shared links- PersonBrian Huntly
Shares Acute myeloid leukaemia and the tags clinician-scientist, leukaemia, haematology.
- PersonKonstanze Döhner
Shares Acute myeloid leukaemia and the tags clinician-scientist, leukaemia, haematology.
- PersonHubert Serve
Shares Acute myeloid leukaemia and the tags clinician-scientist, leukaemia, haematology.
- PersonThomas Kindler
Shares Acute myeloid leukaemia and the tags clinician-scientist, leukaemia, haematology.
- PersonMartin Bornhäuser
Shares Acute myeloid leukaemia and the tags clinician-scientist, leukaemia, haematology.
- PersonSamra Turajlić
Shares Cancer Research UK Manchester Institute and the tag clinician-scientist.
- PersonNorbert Vey
Shares Acute myeloid leukaemia and the tags clinician-scientist, haematology.
- PersonChristian Brandts
Shares Acute myeloid leukaemia and the tags clinician-scientist, haematology.